Evidence map›Paper›PMID 39994442›Full record

ArticleScientific reports2025

A machine learning method for predicting molecular antimicrobial activity.

Bangjiang Lin, Shujie Yan, Bowen Zhen

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Frontiers in bioinformatics · 2026
    Review
  10. Review
  11. Novel Antibacterial Approaches and Therapeutic Strategies.Antibiotics (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bangjiang LinQuanzhou Institute of Equipment Manufacturing, Haixi Institutes, Chinese Academy of Sciences, Quanzhou, 362216, China. linbangjiang@fjirsm.ac.cn.
Shujie YanQuanzhou Institute of Equipment Manufacturing, Haixi Institutes, Chinese Academy of Sciences, Quanzhou, 362216, China.
Bowen ZhenQuanzhou Institute of Equipment Manufacturing, Haixi Institutes, Chinese Academy of Sciences, Quanzhou, 362216, China.

Funding

Natural Science Foundation of Fujian Province 2022J01499Science and Technology Program of Quanzhou 2023GZ6Special Fund to Promote High Quality Development of the Marine and Fisheries Industry of Fujian Province FJHYF-ZH-2023-09STS Project of CAS and Fujian Province 2024T3038
6 · The paper itself

Abstract

In response to the increasing concern over antibiotic resistance and the limitations of traditional methods in antibiotic discovery, we introduce a machine learning-based method named MFAGCN. This method predicts the antimicrobial efficacy of molecules by integrating three types of molecular fingerprints-MACCS, PubChem, and ECFP-along with molecular graph representations as input features, with a specific focus on molecular functional groups. MFAGCN incorporates an attention mechanism to assign different weights to the importance of information from different neighboring nodes. Comparative experiments with baseline models on two public datasets demonstrate MFAGCN's superior performance. Additionally, we conducted an analysis of the functional group distribution in both the training and test sets to validate the model's predictions. Furthermore, structural similarity analyses with known antibiotics are performed to prevent the rediscovery of established antibiotics. This approach enables researchers to rapidly screen molecules with potent antimicrobial properties and facilitates the identification of functional groups that influence antimicrobial performance, providing valuable insights for further antibiotic development.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug DiscoveryMachine LearningAnti-Bacterial AgentsAnti-Infective Agents

Identifiers

PMID39994442
PMCPMC11850884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.